John N. Eble
- Pulmonary and Respiratory Medicine top 0.05%
- Renal cell carcinoma treatment 98
- Cancer Research top 0.2%
- Cancer Genomics and Diagnostics 41
- Urology top 0.5%
- Urological Disorders and Treatments 30
- Molecular Biology top 0.5%
- Renal and related cancers 93
- Surgery top 0.2%
- Bladder and Urothelial Cancer Treatments 39
- Urinary and Genital Oncology Studies 38
- Testicular diseases and treatments 29
-
- Urologic and reproductive health conditions 38
- Co-authors
- Liang ChengBrett DelahuntDavid J. GrignonGuido MartignoniThomas M. UlbrightJohn R. SrigleyMichael O. KochGregory T. MacLennan
- Journals
- Modern Pathology (41 papers)The American Journal of Surgical Pathology (39 papers)The Journal of Urology (19 papers)
- Partner nations
- United StatesItalySpain
In The Last Decade
John N. Eble
288 papers receiving 16.7k citations
Hit Papers
Peers
Comparison fields: 5 of 153
- Pulmonary and Respiratory Medicine 10.5k
- Cancer Research 3.9k
- Urology 896
- Molecular Biology 9.4k
- Surgery 4.8k
Countries citing papers authored by John N. Eble
This map shows the geographic impact of John N. Eble's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John N. Eble with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John N. Eble more than expected).
Fields of papers citing papers by John N. Eble
This network shows the impact of papers produced by John N. Eble. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John N. Eble. The network helps show where John N. Eble may publish in the future.
Co-authorship network
The 25 scholars most cited alongside John N. Eble, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 34 | |
| 2 | Plasmacytoid/diffuse urothelial carcinoma: a single-institution immunohistochemical and molecular study of 69 patients | 2019 | 1 |
| 3 | 2018 | 151 | |
| 4 | 2016 | 19 | |
| 5 | 2016 | 7 | |
| 6 | 2013 | 24 | |
| 7 | 2008 | 24 | |
| 8 | Pathology and genetics of tumours of the urinary system and male genital organsbreakdown → | 2004 | 806 |
| 9 | 2004 | 206 | |
| 10 | 2004 | 80 | |
| 11 | 2002 | 43 | |
| 12 | 2001 | 44 | |
| 13 | 1997 | 17 | |
| 14 | A symposium on controversies in the pathology of transitional cell carcinomas of the urinary bladder, Part II. | 1996 | 11 |
| 15 | 1994 | 84 | |
| 16 | Tumors and tumor-like conditions of the kidneys and ureters | 1990 | 17 |
| 17 | 1989 | 3 | |
| 18 | 1983 | 11 | |
| 19 | 1964 | 9 | |
| 20 | 1964 | 129 |
About John N. Eble
John N. Eble is a scholar working on Urology, Pulmonary and Respiratory Medicine and Cancer Research, having authored 290 papers that have together received 17.2k indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (98 papers), Renal and related cancers (93 papers), Cancer Genomics and Diagnostics (41 papers), Bladder and Urothelial Cancer Treatments (39 papers), Urinary and Genital Oncology Studies (38 papers), Urologic and reproductive health conditions (38 papers), Urological Disorders and Treatments (30 papers) and Testicular diseases and treatments (29 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (10.5k citations), Cancer Research (3.9k citations) and Urology (896 citations). John N. Eble has collaborated with scholars based in United States, Italy and Spain. Frequent co-authors include Liang Cheng, Brett Delahunt, David J. Grignon, Guido Martignoni, Thomas M. Ulbright, Brett Delahunt, John R. Srigley, Michael O. Koch, Gregory T. MacLennan and Timothy D. Jones. Their work appears in journals such as Modern Pathology, The American Journal of Surgical Pathology, The Journal of Urology, Human Pathology and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.